BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18019971)

  • 21. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
    Fedson DS
    Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
    Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cost-of-illness study of pneumococcal disease in Italian children].
    Colombo GL
    Ann Ig; 2002; 14(5):373-88. PubMed ID: 12508446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.
    Mangtani P; Roberts JA; Hall AJ; Cutts FT
    Int J Epidemiol; 2005 Jun; 34(3):565-74. PubMed ID: 15764694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia.
    Kruspe R; Lillis R; Daberkow DW; Blais CM; Wilbright W; Gupta S; Gould CA; Sun T; Martinez JA; deBoisblanc B; Ladabaum U; Sanders CV; Lopez FA
    J La State Med Soc; 2003; 155(6):325-31. PubMed ID: 14750752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents.
    Nuorti JP; Butler JC; Crutcher JM; Guevara R; Welch D; Holder P; Elliott JA
    N Engl J Med; 1998 Jun; 338(26):1861-8. PubMed ID: 9637804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Economic aspects of hospitaly treated pneumococcal pneumonia and the results of Pneumo 23 vaccine use in Serbia].
    Adzić T; Rosić I; Jovanović D; Medić-Stojanac S
    Srp Arh Celok Lek; 2008; 136(11-12):625-8. PubMed ID: 19177825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
    Albrich WC; Baughman W; Schmotzer B; Farley MM
    Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population.
    Wexler ID; Knoll S; Picard E; Villa Y; Shoseyov D; Engelhard D; Kerem E
    Pediatr Pulmonol; 2006 Aug; 41(8):726-34. PubMed ID: 16779839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A population-based assessment of the disease burden of consolidated pneumonia in hospitalized children under five years of age.
    Hortal M; Estevan M; Iraola I; De Mucio B
    Int J Infect Dis; 2007 May; 11(3):273-7. PubMed ID: 16997592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Assessment of the contribution of the immunochromatographic pneumococcal urinary antigen test to the etiological diagnosis of pneumonia in hospitalized adults].
    Segonds C; Le Goff A; Chabanon G
    Pathol Biol (Paris); 2010 Apr; 58(2):117-22. PubMed ID: 19875240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
    Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR
    Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany.
    Zeidler J; Mittendorf T; Vahldiek G; Zeidler H; Merkesdal S
    Rheumatology (Oxford); 2008 Oct; 47(10):1527-34. PubMed ID: 18682412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia.
    Johnstone J; Eurich DT; Minhas JK; Marrie TJ; Majumdar SR
    Clin Infect Dis; 2010 Jul; 51(1):15-22. PubMed ID: 20504233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current use of penicillin in community-acquired pneumococcal pneumonias].
    Gaztelurrutia L; Zalacaín R; Rubio G; Hernández JL; Urra E; Hernández M; Garea C; Barrón J
    Enferm Infecc Microbiol Clin; 1994 Jan; 12(1):17-20. PubMed ID: 8155749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia.
    Hedlund JU; Kalin ME; Ortqvist AB; Henrichsen J
    Arch Intern Med; 1994 Sep; 154(17):1961-5. PubMed ID: 8074600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.
    Zhou F; Kyaw MH; Shefer A; Winston CA; Nuorti JP
    Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1162-8. PubMed ID: 18056561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumococcal pneumonia in hospitalized Uruguayan children and potential prevention with different vaccine formulations.
    Hortal M; Sehabiague G; Camou T; Iraola I; Estevan M; Pujadas M
    J Pediatr; 2008 Jun; 152(6):850-3. PubMed ID: 18492530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.